Literature DB >> 15670608

Reversal of protein aggregation provides evidence for multiple aggregated States.

Martino Calamai1, Claudio Canale, Annalisa Relini, Massimo Stefani, Fabrizio Chiti, Christopher M Dobson.   

Abstract

Observations that prefibrillar aggregates from different amyloidogenic proteins can be solubilised under some conditions have raised questions as to the generality of this phenomenon and the nature of the factors that influence it. By studying aggregates formed from human muscle acylphosphatase (AcP) under mild denaturing conditions, and by using a battery of techniques, we demonstrate that disaggregation is possible under conditions close to physiological where the protein is stable in its native state. In the presence of 25% (v/v) trifluoroethanol (TFE) AcP undergoes partial unfolding and globular aggregates (60-200 nm in diameter) that can assemble further into clusters (400-800 nm in diameter) develop progressively. Yet larger superstructures (>5 microm) are formed when the concentration of the globular aggregates exceeds a critical concentration. After diluting the sample to give a solution containing 5% TFE, the fraction of partially unfolded monomeric protein refolds very rapidly, with a rate constant of approximately 1s(-1). The 60-200 nm globular aggregates disaggregate with an apparent rate constant of approximately 2.5 x 10(-3)s(-1) while the 400-800 nm clusters disassembly more slowly with a rate constant of approximately 3.1 x 10(-4)s(-1). The larger (>5 microm) superstructures are not disrupted under the conditions used here. These results suggest that amyloid formation occurs in discrete steps whose reversibility is increasingly difficult, and dependent on the size of the aggregates, and that disaggregation experiments can provide a powerful method of detecting different types of species within the complex process of aggregation. In addition, our work suggests that destabilization of amyloid aggregates resulting in the conversion of misfolded proteins back to their native states could be an important factor in both the onset and treatment of diseases associated with protein aggregation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15670608     DOI: 10.1016/j.jmb.2004.11.067

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  22 in total

1.  An oligomeric equilibrium intermediate as the precursory nucleus of globular and fibrillar supramacromolecular assemblies in a PDZ domain.

Authors:  Javier Murciano-Calles; Eva S Cobos; Pedro L Mateo; Ana Camara-Artigas; Jose C Martinez
Journal:  Biophys J       Date:  2010-07-07       Impact factor: 4.033

2.  Suppression, disaggregation, and modulation of γ-Synuclein fibrillation pathway by green tea polyphenol EGCG.

Authors:  Sneha Roy; Rajiv Bhat
Journal:  Protein Sci       Date:  2018-12-20       Impact factor: 6.725

Review 3.  Protein particulate detection issues in biotherapeutics development--current status.

Authors:  Tapan K Das
Journal:  AAPS PharmSciTech       Date:  2012-05-08       Impact factor: 3.246

4.  Surface adsorption considerations when working with amyloid fibrils in multiwell plates and Eppendorf tubes.

Authors:  Amber N Murray; Fernando L Palhano; Jan Bieschke; Jeffery W Kelly
Journal:  Protein Sci       Date:  2013-09-30       Impact factor: 6.725

5.  Amyloid features and neuronal toxicity of mature prion fibrils are highly sensitive to high pressure.

Authors:  Driss El Moustaine; Veronique Perrier; Isabelle Acquatella-Tran Van Ba; Filip Meersman; Valeriy G Ostapchenko; Ilia V Baskakov; Reinhard Lange; Joan Torrent
Journal:  J Biol Chem       Date:  2011-02-25       Impact factor: 5.157

6.  Quantitative Characterization of Metastability and Heterogeneity of Amyloid Aggregates.

Authors:  Timir Baran Sil; Bankanidhi Sahoo; Subhas Chandra Bera; Kanchan Garai
Journal:  Biophys J       Date:  2018-02-27       Impact factor: 4.033

7.  Protein aggregate formation permits millennium-old brain preservation.

Authors:  Axel Petzold; Ching-Hua Lu; Mike Groves; Johan Gobom; Henrik Zetterberg; Gerry Shaw; Sonia O'Connor
Journal:  J R Soc Interface       Date:  2020-01-08       Impact factor: 4.118

8.  Antimicrobial functionalized genetically engineered spider silk.

Authors:  Sílvia C Gomes; Isabel B Leonor; João F Mano; Rui L Reis; David L Kaplan
Journal:  Biomaterials       Date:  2011-03-31       Impact factor: 12.479

9.  The (1-63) region of the p53 transactivation domain aggregates in vitro into cytotoxic amyloid assemblies.

Authors:  Stefania Rigacci; Monica Bucciantini; Annalisa Relini; Alessandra Pesce; Alessandra Gliozzi; Andrea Berti; Massimo Stefani
Journal:  Biophys J       Date:  2008-01-16       Impact factor: 4.033

10.  Direct observation of defects and increased ion permeability of a membrane induced by structurally disordered Cu/Zn-superoxide dismutase aggregates.

Authors:  Inhee Choi; Hyeon Don Song; Suseung Lee; Young In Yang; Joo Hyun Nam; Sung Joon Kim; Jung-Joon Sung; Taewook Kang; Jongheop Yi
Journal:  PLoS One       Date:  2011-12-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.